Diabetes :: How to achieve strict glycaemic control in type 2 diabetes
Effective treatment of hyperglycaemia and strict glycaemic control are key to reducing microvascular complications in patients with type 2 diabetes.
Effective treatment of hyperglycaemia and strict glycaemic control are key to reducing microvascular complications in patients with type 2 diabetes.
Diabetes patients starting out on GlaxoSmithKline drug Avandia have a better chance of keeping blood sugar levels within safe limits than those given older medicines, revealed after a clinical trial by Glaxo.
The December 2006 issue of the Journal of the American Dietetic Association contains articles and research studies you may find of interest. Below is a summary of some of this month’s articles.
Researchers at New York University and the Scripps Research Institute have discovered a new enzyme, GAPDH, which regulates insulin pathways — a finding that offers a new direction for the treatment of diabetes. The research is reported in the most recent issue of the journal Nature Chemical Biology.
With nearly 21 million Americans today suffering from diabetes and as many as 6.2 million unaware that they have the disease, the Pharmaceutical Research and Manufacturers of America (PhRMA) launched a new multi-media national health education campaign on diabetes awareness.
King Pharmaceuticals, Inc. (NYSE: KG) and Depomed, Inc. (NASDAQ: DEPO) today announced the launch of a new program that will provide support for patients with diabetes who are receiving treatment with Glumetza (metformin hydrochloride extended-release tablets), a new once-daily extended-release metformin formulation that features AcuForm drug-delivery technology.
New data published in the Nov. 24 issue of Science provide further support for a protocol to reverse type 1 diabetes in mice and new evidence that adult precursor cells from the spleen can contribute to the regeneration of beta cells.
People who suffer from job burnout may be prone to developing type 2 diabetes, according to a study of 677 mostly male middle-aged Israeli workers, published in the journal Psychosomatic Medicine.
Within the next 10 years the EU-funded Diabetes Prevention study, part of an international study called TRIGR (Trial to Reduce IDDM in the Genetically at Risk), coordinated at the University of Helsinki, Finland, will generate a definite answer to the question whether early nutritional modification may prevent type 1 diabetes later in childhood.
There is a strong link between panic episodes and increased complications from diabetes, according to a study conducted at Group Health Cooperative, a Seattle-based health system. The work appears in the November issue of General Hospital Psychiatry. Of the 4,385 patients surveyed, 193 reported experiencing recent episodes of panic. Panic episodes were associated with higher blood sugar levels, increased diabetic complications and symptoms, greater disability and lower self-rated health and functioning.